Cargando…

Total delay in treatment among tuberculous meningitis patients in China: a retrospective cohort study

BACKGROUND: Currently, there is limited data on the risk factors associated with treatment delay in tuberculous meningitis (TBM). This study aimed to assess the duration of delay in the treatment TBM and to investigate its determinants. METHODS: During the period from September 2009 to February 2016...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yu, Han, Chao, Chang, Kai-Feng, Wang, Mao-Shui, Huang, Tian-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429562/
https://www.ncbi.nlm.nih.gov/pubmed/28499348
http://dx.doi.org/10.1186/s12879-017-2447-0
_version_ 1783236047999598592
author He, Yu
Han, Chao
Chang, Kai-Feng
Wang, Mao-Shui
Huang, Tian-Ren
author_facet He, Yu
Han, Chao
Chang, Kai-Feng
Wang, Mao-Shui
Huang, Tian-Ren
author_sort He, Yu
collection PubMed
description BACKGROUND: Currently, there is limited data on the risk factors associated with treatment delay in tuberculous meningitis (TBM). This study aimed to assess the duration of delay in the treatment TBM and to investigate its determinants. METHODS: During the period from September 2009 to February 2016, a retrospective cohort study of consecutive TBM patients admitted to our hospital was conducted to determine the risk factors associated with treatment delay in TBM. Treatment delay duration was defined as the time interval from onset of symptoms (by patient recall) to initiation of treatment and was stratified into two categories: ≤ 20 days, >20 days (median delay day is 20 days). Data collected included demography, comorbidity, cerebrospinal fluid (CSF) examinations and others. Univariable and multivariable logistic regression analysis was used to evaluate the determinants of treatment delay. RESULTS: A total of 161 TBM patients were included in our study, all were confirmed by CSF mycobacterial culture. The median treatment delay for all patients included in the study was 20 days [interquartile range, 14–60 days]. Multivariate analysis revealed that age (≤21 years old, OR = 0.202, 95% CI: 0.079, 0.521), fever (OR = 0.414, 95% CI: 0.180, 0.952), and headache (OR = 0.204, 95% CI: 0.095, 0.442) had significantly lower risk for treatment delay, while multiple healthcare contact (>3 times) (OR = 3.938, 95% CI: 1.326, 11.691) as well as CSF chloride (>111 mmol/L) (OR = 2.479, 95% CI: 1.143, 5.377) had significantly higher risk of the delay. CONCLUSIONS: Our findings indicate that multiple healthcare contact and high CSF chloride predict the risk of long delay, while young age, fever and headache are associated with short delay. Maintained focus on awareness of TBM in the population and in healthcare systems, and continuous implementation of diagnostic methods for TBM to detect the disease early, may reduce the mortality and morbidity.
format Online
Article
Text
id pubmed-5429562
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54295622017-05-15 Total delay in treatment among tuberculous meningitis patients in China: a retrospective cohort study He, Yu Han, Chao Chang, Kai-Feng Wang, Mao-Shui Huang, Tian-Ren BMC Infect Dis Research Article BACKGROUND: Currently, there is limited data on the risk factors associated with treatment delay in tuberculous meningitis (TBM). This study aimed to assess the duration of delay in the treatment TBM and to investigate its determinants. METHODS: During the period from September 2009 to February 2016, a retrospective cohort study of consecutive TBM patients admitted to our hospital was conducted to determine the risk factors associated with treatment delay in TBM. Treatment delay duration was defined as the time interval from onset of symptoms (by patient recall) to initiation of treatment and was stratified into two categories: ≤ 20 days, >20 days (median delay day is 20 days). Data collected included demography, comorbidity, cerebrospinal fluid (CSF) examinations and others. Univariable and multivariable logistic regression analysis was used to evaluate the determinants of treatment delay. RESULTS: A total of 161 TBM patients were included in our study, all were confirmed by CSF mycobacterial culture. The median treatment delay for all patients included in the study was 20 days [interquartile range, 14–60 days]. Multivariate analysis revealed that age (≤21 years old, OR = 0.202, 95% CI: 0.079, 0.521), fever (OR = 0.414, 95% CI: 0.180, 0.952), and headache (OR = 0.204, 95% CI: 0.095, 0.442) had significantly lower risk for treatment delay, while multiple healthcare contact (>3 times) (OR = 3.938, 95% CI: 1.326, 11.691) as well as CSF chloride (>111 mmol/L) (OR = 2.479, 95% CI: 1.143, 5.377) had significantly higher risk of the delay. CONCLUSIONS: Our findings indicate that multiple healthcare contact and high CSF chloride predict the risk of long delay, while young age, fever and headache are associated with short delay. Maintained focus on awareness of TBM in the population and in healthcare systems, and continuous implementation of diagnostic methods for TBM to detect the disease early, may reduce the mortality and morbidity. BioMed Central 2017-05-12 /pmc/articles/PMC5429562/ /pubmed/28499348 http://dx.doi.org/10.1186/s12879-017-2447-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
He, Yu
Han, Chao
Chang, Kai-Feng
Wang, Mao-Shui
Huang, Tian-Ren
Total delay in treatment among tuberculous meningitis patients in China: a retrospective cohort study
title Total delay in treatment among tuberculous meningitis patients in China: a retrospective cohort study
title_full Total delay in treatment among tuberculous meningitis patients in China: a retrospective cohort study
title_fullStr Total delay in treatment among tuberculous meningitis patients in China: a retrospective cohort study
title_full_unstemmed Total delay in treatment among tuberculous meningitis patients in China: a retrospective cohort study
title_short Total delay in treatment among tuberculous meningitis patients in China: a retrospective cohort study
title_sort total delay in treatment among tuberculous meningitis patients in china: a retrospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429562/
https://www.ncbi.nlm.nih.gov/pubmed/28499348
http://dx.doi.org/10.1186/s12879-017-2447-0
work_keys_str_mv AT heyu totaldelayintreatmentamongtuberculousmeningitispatientsinchinaaretrospectivecohortstudy
AT hanchao totaldelayintreatmentamongtuberculousmeningitispatientsinchinaaretrospectivecohortstudy
AT changkaifeng totaldelayintreatmentamongtuberculousmeningitispatientsinchinaaretrospectivecohortstudy
AT wangmaoshui totaldelayintreatmentamongtuberculousmeningitispatientsinchinaaretrospectivecohortstudy
AT huangtianren totaldelayintreatmentamongtuberculousmeningitispatientsinchinaaretrospectivecohortstudy